scholarly journals Tai Chi Chuan Exercise Decreases A1C Levels Along With Increase of Regulatory T-Cells and Decrease of Cytotoxic T-Cell Population in Type 2 Diabetic Patients

Diabetes Care ◽  
2007 ◽  
Vol 30 (3) ◽  
pp. 716-718 ◽  
Author(s):  
S.-H. Yeh ◽  
H. Chuang ◽  
L.-W. Lin ◽  
C.-Y. Hsiao ◽  
P.-W. Wang ◽  
...  
Keyword(s):  
T Cells ◽  
T Cell ◽  
Regulatory T Cells ◽  
Tai Chi ◽  
Cytotoxic T Cell ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Tai Chi Chuan ◽  
Type 2 Diabetic

scholarly journals Effect of 3 Months of Doxazosin Therapy on T-Cell Subsets in Type 2 Diabetic Patients

2009 ◽  
Vol 37 (6) ◽  
pp. 1982-1987 ◽  
Author(s):  
E Mácsai ◽  
Á Cseh ◽  
G Budai ◽  
G Mészáros ◽  
B Vásárhelyi ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Subsets ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

scholarly journals Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients

2015 ◽  
Vol 125 (4) ◽  
pp. 1752-1762 ◽  
Author(s):  
Isabelle Magalhaes ◽  
Karine Pingris ◽  
Christine Poitou ◽  
Stéphanie Bessoles ◽  
Nicolas Venteclef ◽  
...  
Keyword(s):  
T Cell ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Cell Alterations ◽  
Type 2 Diabetic

scholarly journals Activation-Induced Cell Death of Mucosal-Associated Invariant T Cells Is Amplified by OX40 in Type 2 Diabetic Patients

2019 ◽  
Vol 203 (10) ◽  
pp. 2614-2620 ◽  
Author(s):  
Mei Zhang ◽  
Siqi Ming ◽  
Sitang Gong ◽  
Siping Liang ◽  
Yuanmei Luo ◽  
...  
Keyword(s):  
T Cells ◽  
Cell Death ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Activation Induced Cell Death ◽  
Invariant T Cells ◽  
Type 2 Diabetic

Vitamin D3 supplementation improves glycemic control in type 2 diabetic patients: Results from an Italian clinical trial

2020 ◽  
pp. 1-10
Author(s):  
Giuseppe Derosa ◽  
Angela D’Angelo ◽  
Chiara Martinotti ◽  
Maria Chiara Valentino ◽  
Sergio Di Matteo ◽  
...  
Keyword(s):  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Metabolic Control ◽  
Vitamin D3 ◽  
Therapy Group ◽  
Hypoglycemic Agents ◽  
Diabetic Patients ◽  
Type 2 Diabetic Patients ◽  
Type 2 Diabetic

Abstract. Background: to evaluate the effects of Vitamin D3 on glyco-metabolic control in type 2 diabetic patients with Vitamin D deficiency. Methods: one hundred and seventeen patients were randomized to placebo and 122 patients to Vitamin D3. We evaluated anthropometric parameters, glyco-metabolic control, and parathormone (PTH) value at baseline, after 3, and 6 months. Results: a significant reduction of fasting, and post-prandial glucose was recorded in Vitamin D3 group after 6 months. A significant HbA1c decrease was observed in Vitamin D3 (from 7.6% or 60 mmol/mol to 7.1% or 54 mmol) at 6 months compared to baseline, and to placebo (p < 0.05 for both). At the end of the study period, we noticed a change in the amount in doses of oral or subcutaneous hypoglycemic agents and insulin, respectively. The use of metformin, acarbose, and pioglitazone was significantly lower (p = 0.037, p = 0.048, and p = 0.042, respectively) than at the beginning of the study in the Vitamin D3 therapy group. The units of Lispro, Aspart, and Glargine insulin were lower in the Vitamin D3 group at the end of the study (p = 0.031, p = 0.037, and p = 0.035, respectively) than in the placebo group. Conclusions: in type 2 diabetic patients with Vitamin D deficiency, the restoration of value in the Vitamin D standard has led not only to an improvement in the glyco-metabolic compensation, but also to a reduced posology of some oral hypoglycemic agents and some types of insulin used.

Sign in / Sign up

Export Citation Format

Share Document